Wuxi Bio (02269) repurchased 2.89 million shares for 99.825 million Hong Kong dollars on June 30th.
WuXi Biologics (02269) announced that it will spend 99.825 million Hong Kong dollars to repurchase 2.89 million shares on June 30, 2026.
WUXI BIO (02269) announced that on June 30, 2026, they spent 99.825 million Hong Kong dollars to repurchase 2.89 million shares.
On June 30, 2026, 10,100 shares were issued as a result of exercising options under the company's pre-purchase stock option plan adopted on January 5, 2016 (revised on August 10, 2016).
Related Articles
COSCO SHIPPING Development(02866) plans to invest 8.656 billion yuan to acquire a total of 24 vessels.
REALWAY CAPITAL(01835): Change of controlling shareholder, offering a cash offer of approximately 39.39% discount and will resume trading on July 2nd.
HUNLICAR GROUP (03638) announced its annual performance, with a net profit attributable to shareholders of HK$28.166 million.
COSCO SHIPPING Development(02866) plans to invest 8.656 billion yuan to acquire a total of 24 vessels.
REALWAY CAPITAL(01835): Change of controlling shareholder, offering a cash offer of approximately 39.39% discount and will resume trading on July 2nd.
HUNLICAR GROUP (03638) announced its annual performance, with a net profit attributable to shareholders of HK$28.166 million.
RECOMMEND
